Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

144 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cellular, Molecular and Proteomic Characteristics of Early Hepatocellular Carcinoma.
Armakolas A, Dimopoulou V, Nezos A, Stamatakis G, Samiotaki M, Panayotou G, Tampaki M, Stathaki M, Dourakis S, Koskinas J. Armakolas A, et al. Among authors: koskinas j. Curr Issues Mol Biol. 2022 Oct 10;44(10):4714-4734. doi: 10.3390/cimb44100322. Curr Issues Mol Biol. 2022. PMID: 36286037 Free PMC article.
Liquid Biopsies, Novel Approaches and Future Directions.
Armakolas A, Kotsari M, Koskinas J. Armakolas A, et al. Among authors: koskinas j. Cancers (Basel). 2023 Mar 3;15(5):1579. doi: 10.3390/cancers15051579. Cancers (Basel). 2023. PMID: 36900369 Free PMC article. Review.
High levels of HCV core+1 antibodies in HCV patients with hepatocellular carcinoma.
Dalagiorgou G, Vassilaki N, Foka P, Boumlic A, Kakkanas A, Kochlios E, Khalili S, Aslanoglou E, Veletza S, Orfanoudakis G, Vassilopoulos D, Hadziyannis SJ, Koskinas J, Mavromara P. Dalagiorgou G, et al. Among authors: koskinas j. J Gen Virol. 2011 Jun;92(Pt 6):1343-1351. doi: 10.1099/vir.0.023010-0. Epub 2011 Feb 9. J Gen Virol. 2011. PMID: 21307221
Five-Years Outcome Analysis of 142 Consecutive Hepatocellular Carcinoma Patients Treated with Doxorubicin Eluting Microspheres 30-60 μm: Results from a Single-Centre Prospective Phase II Trial.
Malagari K, Moschouris H, Kiakidis T, Harward S, Kelekis A, Vrakas S, Koundouras D, Filipiadis D, Glantzounis G, Emmanouil E, Chatziioannou A, Vergadis V, Elefsiniotis I, Koskinas J, Dourakis S, Kelekis N. Malagari K, et al. Among authors: koskinas j. Cardiovasc Intervent Radiol. 2019 Nov;42(11):1551-1562. doi: 10.1007/s00270-019-02260-3. Epub 2019 Jul 18. Cardiovasc Intervent Radiol. 2019. PMID: 31321482 Clinical Trial.
144 results